Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;43(3):368-376.
doi: 10.1016/j.jgr.2017.11.002. Epub 2017 Nov 26.

Differentiation and identification of ginsenoside structural isomers by two-dimensional mass spectrometry combined with statistical analysis

Affiliations

Differentiation and identification of ginsenoside structural isomers by two-dimensional mass spectrometry combined with statistical analysis

Yang Xiu et al. J Ginseng Res. 2019 Jul.

Abstract

Background: In the current phytochemical research on ginseng, the differentiation and structural identification of ginsenosides isomers remain challenging. In this paper, a two-dimensional mass spectrometry (2D-MS) method was developed and combined with statistical analysis for the direct differentiation, identification, and relative quantification of protopanaxadiol (PPD)-type ginsenoside isomers.

Methods: Collision-induced dissociation was performed at successive collision energy values to produce distinct profiles of the intensity fraction (IF) and ratio of intensity (RI) of the fragment ions. To amplify the differences in tandem mass spectra between isomers, IF and RI were plotted against collision energy. The resulting data distributions were then used to obtain the parameters of the fitted curves, which were used to evaluate the statistical significance of the differences between these distributions via the unpaired t test.

Results: A triplet and two pairs of PPD-type ginsenoside isomers were differentiated and identified by their distinct IF and RI distributions. In addition, the fragmentation preference of PPD-type ginsenosides was determined on the basis of the activation energy. The developed 2D-MS method was also extended to quantitatively determine the molar composition of ginsenoside isomers in mixtures of biotransformation products.

Conclusion: In comparison with conventional mass spectrometry methods, 2D-MS provides more direct insights into the subtle structural differences between isomers and can be used as an alternative approach for the differentiation of isomeric ginsenosides and natural products.

Keywords: Differentiation; Ginsenoside isomers; Relative quantification; Two-dimensional mass spectrometry.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The structures of isomeric ginsenosides Rb2, Rb3, and Rc and their possible fragmentation pathways in CID experiments. Arap, arabinopyranosyl; araf, arabinofuranosyl; CID, collision-induced dissociation; xyl, xylopyranosyl.
Fig. 2
Fig. 2
2D-MS analyses of ginsenoside Rb2 in the positive ion mode. The figure was obtained by overlapping the tandem MS spectra on the precursor ion at m/z 1101 using continuously varied CE in SRM mode, indicating that the intensities of the fragment ions varied with the CE. CE, collision energy; 2D-MS, two-dimensional mass spectrometry; MS, mass spectrometry; SRM, selected reaction monitor.
Fig. 3
Fig. 3
The IF and RI distributions of the ions for ginsenosides Rb2, Rb3, and Rc. (A) The IF distributions of the ions at m/z 335. (B) The RI distributions of the ions at m/z 335 to m/z 789. Each of the distributions was fitted by 5th order polynomial function with the correlation coefficients (R2) shown in the inset, the same below. IF, intensity fraction; RI, ratio of intensity
Fig. 4
Fig. 4
The negative MS2 spectra from the [M-H]- ion at m/z 783 of ginsenosides under the CE of 12 eV. (A) Ginsenoside Rg3. (B) Ginsenoside F2. Both of the two isomers were fragmented by successive losses of glucose residues and alkene chain. The insets showed the possible fragmentation pathways to generate each fragment ion in the spectra. CE, collision energy.
Fig. 5
Fig. 5
The RI distributions of the ions at m/z 459 to m/z 621 for ginsenosides Rg3 and F2, which can be differentiated based on the RI value at 0.9 in the CE range of 20–80 eV. CE, collision energy; RI, ratio of intensity.
Fig. 6
Fig. 6
The IF distributions for ginsenosides Rh2 and C-K. (A) The IF distributions of the ions at m/z 459 for ginsenoside Rh2, which can be differentiated based on the IF values at 25% in the CE range of 12–64 eV. (B) The IF distributions of the ions at m/z 375 for ginsenoside C-K, which can be differentiated based on the IF values at 3.8% in the CE range of 32–80 eV. CE, collision energy; IF, intensity fraction.
Fig. 7
Fig. 7
The establishment of standard curve of the first approach for the relative quantification of ginsenoside isomers. (A) The linear relationship between the IF values of the m/z 459 ion and the CE for each mixture of Rh2 and C-K. (B) The linear relationship between the slope of each regression line in panel (A) and the molar composition of each mixture. CE, collision energy; IF, intensity fraction.
Fig. 8
Fig. 8
The relative quantification of ginsenoside isomers in biotransformation product. (A) The mass spectrum of the biotransformation product of PPD-type ginsenosides. (B) The linear relationship between the varying CE and the IF values of the m/z 459 and m/z 621 ions for Rh2/C-K and Rg3/F2, respectively. CE, collision energy; IF, intensity fraction; PPD, protopanaxadiol.

Similar articles

Cited by

References

    1. State Pharmacopoeia Committee . China Medical Science and Technology Press; Beijing: 2010. Pharmacopoeia of the People’s Republic of China.
    1. Liu Z.Q. Chemical insights into ginseng as a resource for natural antioxidants. Chem Rev. 2012;112:3329–3355. - PubMed
    1. Ganesan P., Ko H.M., Kim I.S., Choi D.K. Recent trends of nano bioactive compounds from ginseng for its possible preventive role in chronic disease models. RSC Adv. 2015;5:98634–98642.
    1. Wong A.S.T., Che C.M., Leung K.W. Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview. Nat Prod Rep. 2015;32:256–272. - PubMed
    1. Li K.K., Gong X.J. A review on the medicinal potential of Panax ginseng saponins in diabetes mellitus. RSC Adv. 2015;5:47353–47366.